Bio-Rad Laboratories (STU:BUWA) Cyclically Adjusted Book per Share: €255.18 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BUWA Bio-Rad Laboratories Inc STU:BUWA
71 GF Score
Price €333.00
GF Value €276.66
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bio-Rad Laboratories Cyclically Adjusted Book per Share?

Bio-Rad Laboratories STU:BUWA +0.67% 71 Cyclically Adjusted Book per Share is €255.18 as of Jun. 2026. GuruFocus rates STU:BUWA with a GF Score™ of 71/100 and a GF Value™ of €276.66 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted book value per share for the three months ended in Jun. 2026 was €234.675. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €255.18 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted Book Growth Rate was 9.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Rad Laboratories was 26.60% per year. The lowest was 9.10% per year. And the median was 15.20% per year.

As of today (2026-09-18), Bio-Rad Laboratories's current stock price is €333.00. Bio-Rad Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €255.18. Bio-Rad Laboratories's Cyclically Adjusted PB Ratio of today is 1.30.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Rad Laboratories was 5.80. The lowest was 0.86. And the median was 3.02.


Bio-Rad Laboratories  (STU:BUWA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=333.00/255.181
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Rad Laboratories was 5.80. The lowest was 0.86. And the median was 3.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Rad Laboratories Cyclically Adjusted Book per Share Related Terms


Bio-Rad Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Rad Laboratories Cyclically Adjusted Book per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.34 182.50 209.11 229.45 248.40

Bio-Rad Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 234.70 239.11 241.76 249.26 255.18

STU:BUWA vs PODD, GKOS, GMED: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted PB Ratio falls into.


STU:BUWA
71GF Score
Bio-Rad Laboratories Inc STU:BUWA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Rad Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=234.675/333.9520*333.9520
=234.675

Current CPI (Jun. 2026) = 333.9520.

Bio-Rad Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 81.410 241.428 112.609
201612 82.919 241.432 114.695
201703 85.504 243.801 117.121
201706 83.206 244.955 113.436
201709 80.952 246.819 109.530
201712 81.928 246.524 110.983
201803 122.440 249.554 163.849
201806 133.173 251.989 176.489
201809 140.814 252.439 186.283
201812 118.015 251.233 156.872
201903 145.262 254.202 190.835
201906 161.675 256.143 210.787
201909 157.230 256.759 204.500
201912 171.326 256.974 222.648
202003 193.453 258.115 250.292
202006 220.602 257.797 285.769
202009 252.286 260.280 323.695
202012 270.567 260.474 346.892
202103 303.284 264.877 382.375
202106 328.399 271.696 403.648
202109 442.190 274.310 538.333
202112 402.044 278.802 481.573
202203 305.664 287.504 355.046
202206 287.388 296.311 323.895
202209 289.337 296.808 325.546
202212 304.415 296.797 342.524
202303 303.521 301.836 335.816
202306 266.278 305.109 291.450
202309 272.744 307.789 295.928
202312 277.471 306.746 302.081
202403 293.812 312.332 314.150
202406 224.300 314.175 238.419
202409 239.653 315.301 253.829
202412 226.484 315.605 239.650
202503 223.770 319.799 233.673
202506 224.406 322.561 232.331
202509 212.554 324.800 218.543
202512 235.138 324.054 242.320
202603 221.640 330.213 224.150
202606 234.675 333.952 234.675

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €255.18 mean?
Bio-Rad Laboratories (STU:BUWA) has a Cyclically Adjusted Book per Share of €255.18 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Rad Laboratories and its competitors.
Is Bio-Rad Laboratories' Cyclically Adjusted Book per Share too high?
Bio-Rad Laboratories' current Cyclically Adjusted Book per Share is €255.18. Overall, Bio-Rad Laboratories has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bio-Rad Laboratories' Cyclically Adjusted Book per Share compare to PODD and GKOS?
Bio-Rad Laboratories' Cyclically Adjusted Book per Share of €255.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Rad Laboratories and its competitors. Bio-Rad Laboratories's current Cyclically Adjusted Book per Share is €255.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Rad Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Bio-Rad Laboratories (STU:BUWA) is currently considered Modestly Overvalued. The stock's GF Value™ is €276.66, compared to a current price of €333.00 — trading 20.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is €255.18. Bio-Rad Laboratories' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bio-Rad Laboratories (STU:BUWA), the current Cyclically Adjusted Book per Share is €255.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Rad Laboratories (STU:BUWA) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Rad Laboratories stock appears to be overvalued. The current stock price of €333.00 is trading 20.4% above its estimated GF Value™ of €276.66. GuruFocus considers Bio-Rad Laboratories to be Modestly Overvalued.

Key valuation signals for STU:BUWA:

  • Cyclically Adjusted Book per Share: €255.18
  • GF Value™: €276.66 vs. price of €333.00 (20.4% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the STU:BUWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Rad Laboratories Business Description

Other Exchanges BIO.B:USABIO:USA
Address 1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
71GF Score

Get the complete analysis for STU:BUWA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€333.00
Price
€276.66
GF Value